A popular drug prescribed to help people quit smoking may pose a significantly increased risk of heart attack in users, a new study finds. The results may further complicate doctors’ and patients’ ...

When approved by the Food and Drug Administration in 2006, the prescription drug Chantix was heralded as almost a silver bullet in the fight to help people stop smoking. Its ingredient, varenicline, ...

Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. “Will my stop-smoking medication give me a heart attack? I am a ...

LONDON (Reuters) - Pfizer's stop-smoking drug Chantix does not raise risks of heart attack or depression, contrary to previous reports, and should be recommended to more smokers wanting to quit, ...

Pfizer is recalling batches of the anti-smoking drug Chantix because of a high level of a substance that could increase a user’s risk of developing cancer. The Food and Drug Administration (FDA) says ...

Q. What do you think of this drug Chantix to stop smoking? A. Chantix (varenicline) is a prescription drug designed to help smokers quit by stimulating the release of small amounts of dopamine, the ...